{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:34:27Z","timestamp":1761708867123},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,6,28]],"date-time":"2013-06-28T00:00:00Z","timestamp":1372377600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Type 2 diabetes mellitus (T2DM) results from insulin resistance and relative insulin deficiency. T2DM treatment is a step-wise approach beginning with lifestyle modifications (for example, diet, exercise), followed by the addition of oral hypoglycemic agents (for example, metformin). Patients who do not respond to first-line therapy are offered second-line therapy (for example, sulfonylureas). Third-line therapy may include insulin and\/or dipeptidyl peptidase-4 (DPP-4) inhibitors.<\/jats:p>\n            <jats:p>It is unclear whether DPP-4 inhibitors are safer and more effective than intermediate acting insulin for third-line management of T2DM. As such, our objective is to evaluate the comparative effectiveness, safety and cost-effectiveness of DPP-4 inhibitors versus intermediate acting insulin for T2DM patients who have failed both first- and second-line diabetes treatments.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design\/Methods<\/jats:title>\n            <jats:p>Electronic searches of MEDLINE, Cochrane Central Register of Controlled Trials, EMBASE, and grey literature (for example, trial registries, public health websites) will be conducted to identify studies examining DPP-4 inhibitors compared with each other, intermediate acting insulin, no treatment, or placebo for adults with T2DM. The outcomes of interest include glycosylated hemoglobin (A1C) (primary outcome), as well as emergency department visits, physician visits, hospital admissions, weight gain, quality of life, microvascular complications, macrovascular complications, all-cause mortality, and cost (secondary outcomes). Randomized clinical trials (RCTs), quasi-RCTs, non-RCTs, controlled before-after, interrupted time series, cohort studies, and cost studies reporting data on these outcomes will be included. Eligibility will not be restricted by publication status, language of dissemination, duration of study follow-up, or time period of study conduct.<\/jats:p>\n            <jats:p>Two reviewers will screen the titles and abstracts resulting from the literature search, as well as potentially relevant full-text articles, in duplicate. Data will be abstracted and quality will be appraised by two team members independently. Conflicts at all levels of screening and abstraction will be resolved through team discussion.<\/jats:p>\n            <jats:p>Our results will be described narratively. Random effects meta-analysis and network meta-analysis will be conducted, if feasible and appropriate.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>Our systematic review results can be used to determine the most effective, safe and cost-effective third-line strategies for managing T2DM. This information will be of great use to health policy-makers and clinicians, as well as patients living with T2DM and their families.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Systematic review registration<\/jats:title>\n            <jats:p>PROSPERO registry number: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.crd.york.ac.uk\/NIHR_PROSPERO\/display_record.asp?ID=CRD42013003624#.UdL7Pzu-qpc\" ext-link-type=\"uri\">CRD42013003624<\/jats:ext-link>\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/2046-4053-2-47","type":"journal-article","created":{"date-parts":[[2013,6,28]],"date-time":"2013-06-28T18:26:06Z","timestamp":1372443966000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Safety, effectiveness, and cost of dipeptidyl peptidase-4 inhibitors versus intermediate acting insulin for type 2 diabetes: protocol for a systematic review and network meta-analysis"],"prefix":"10.1186","volume":"2","author":[{"given":"Andrea C","family":"Tricco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesmin","family":"Antony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlene","family":"Soobiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda","family":"Hemmelgarn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Moher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Hutton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine H","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumit R","family":"Majumdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon E","family":"Straus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,28]]},"reference":[{"key":"113_CR1","first-page":"487","volume-title":"Diabetes Mellitus","author":"SE Kahn","year":"1997","unstructured":"Kahn SE, Porte D: The pathophysiology of type II (non-insulin dependent) diabetes mellitus: implications for treatment. Diabetes Mellitus. Edited by: Porte D, Sherwin RS. 1997, Stamford, CT: Appleton and Lange, 487-512. 5","edition":"5"},{"issue":"Suppl 1","key":"113_CR2","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.2337\/dc12-s064","volume":"35","author":"American Diabetes Association","year":"2012","unstructured":"American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012, 35 (Suppl 1): S64-S71.","journal-title":"Diabetes Care"},{"key":"113_CR3","unstructured":"Canadian Diabetes Association: The prevalence and costs of diabetes.http:\/\/www.diabetes.ca\/Files\/prevalence-and-costs.pdf,"},{"key":"113_CR4","first-page":"15","volume-title":"Diabetes Public Health: From Data to Policy","author":"LS Geiss","year":"2011","unstructured":"Geiss LS, Cowie CC: Type 2 diabetes and persons at high risk of diabetes. Diabetes Public Health: From Data to Policy. Edited by: Narayan KM, Williams D, Gregg EW, Cowie CC. 2011, New York, NY: Oxford University Press, 15-32."},{"key":"113_CR5","first-page":"S1","volume":"32","author":"Canadian Diabetes Association Clinical Practice Guidelines Expert Committee","year":"2008","unstructured":"Canadian Diabetes Association Clinical Practice Guidelines Expert Committee: Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Canadian Diabetes Association. 2008, 32: S1-S201.","journal-title":"Canadian Diabetes Association"},{"key":"113_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2337\/dc08-9025","volume":"32","author":"DM Nathan","year":"2009","unstructured":"Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B, American Diabetes Association; European Association for Study of Diabetes: Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care. 2009, 32: 193-203. 10.2337\/dc08-9025.","journal-title":"Diabetes Care"},{"key":"113_CR7","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998, 352: 837-853.","journal-title":"Lancet"},{"key":"113_CR8","doi-asserted-by":"publisher","first-page":"995","DOI":"10.2337\/diacare.28.5.995","volume":"28","author":"MN Cook","year":"2005","unstructured":"Cook MN, Girman CJ, Stein PP, Alexander CM, Holman RR: Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes. Diabetes Care. 2005, 28: 995-1000. 10.2337\/diacare.28.5.995.","journal-title":"Diabetes Care"},{"key":"113_CR9","volume-title":"Cochrane Database Syst Rev","author":"B Richter","year":"2008","unstructured":"Richter B, Bandeira-Echtler E, Bergerhoff K, Lerch CL: Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2008, 2: CD006739"},{"key":"113_CR10","volume-title":"19th Cochrane Colloquium; October 19\u201322","author":"D Moher","year":"2011","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shakelle P, Stewart L: Reporting Guidelines for Systematic Review Protocols. 19th Cochrane Colloquium; October 19\u201322. 2011, Madrid, Spain:"},{"key":"113_CR11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1053\/apnr.2002.34181","volume":"15","author":"PW Stone","year":"2002","unstructured":"Stone PW: Popping the (PICO) question in research and evidence-based practice. Appl Nurs Res. 2002, 15: 197-198. 10.1053\/apnr.2002.34181.","journal-title":"Appl Nurs Res"},{"key":"113_CR12","doi-asserted-by":"publisher","first-page":"672","DOI":"10.7326\/0003-4819-154-10-201105170-00007","volume":"154","author":"JL Gross","year":"2011","unstructured":"Gross JL, Kramer CK, Leitao CB, Hawkins N, Viana LV, Schaan BD, Pinto LC, Rodrigues TC, Azevedo MJ, Diabetes and Endocrinology Meta-analysis Group: Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: a network meta-analysis. Ann Intern Med. 2011, 154: 672-679. 10.7326\/0003-4819-154-10-201105170-00007.","journal-title":"Ann Intern Med"},{"key":"113_CR13","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.jclinepi.2008.10.012","volume":"62","author":"M Sampson","year":"2009","unstructured":"Sampson M, McGowan J, Cogo E, Grimshaw J, Moher D, Lefebvre C: An evidence-based practice guideline for the peer review of electronic search strategies. J Clin Epidemiol. 2009, 62: 944-952. 10.1016\/j.jclinepi.2008.10.012.","journal-title":"J Clin Epidemiol"},{"key":"113_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics. 1977, 33: 159-174. 10.2307\/2529310.","journal-title":"Biometrics"},{"key":"113_CR15","volume-title":"SysRev Tool","author":"SR Tool","year":"2011","unstructured":"Tool SR: SysRev Tool. 2011, Toronto: Canada"},{"key":"113_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2288-9-10","volume":"9","author":"SJ Senn","year":"2009","unstructured":"Senn SJ: Overstating the evidence: double counting in meta-analysis and related problems. BMC Med Res Method. 2009, 9: 10-10.1186\/1471-2288-9-10.","journal-title":"BMC Med Res Method"},{"key":"113_CR17","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, Tugwell P: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/nos_manual.pdf,"},{"key":"113_CR18","unstructured":"Cochrane Effective Practice and Organisation of Care Group Draft Risk of Bias Tool.http:\/\/epoc.cochrane.org\/sites\/epoc.cochrane.org\/files\/uploads\/Suggested%20risk%20of%20bias%20criteria%20for%20EPOC%20reviews.pdf,"},{"key":"113_CR19","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997, 315: 629-634. 10.1136\/bmj.315.7109.629.","journal-title":"BMJ"},{"key":"113_CR20","volume-title":"Unpublished report","author":"P Santaguida","year":"2008","unstructured":"Santaguida P, Raina P, Ismaila A: The development of the McHarm quality assessment scale for adverse events. Unpublished report. 2008"},{"key":"113_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials. 1986, 7: 177-188. 10.1016\/0197-2456(86)90046-2.","journal-title":"Control Clin Trials"},{"key":"113_CR22","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med. 2002, 21: 1539-1558. 10.1002\/sim.1186.","journal-title":"Stat Med"},{"key":"113_CR23","volume-title":"Meta-regression Approaches","author":"Agency for Healthcare Research and Quality (AHRQ)","year":"2004","unstructured":"Agency for Healthcare Research and Quality (AHRQ): Meta-regression Approaches. 2004, Rockville, MD: Agency for Healthcare Research and Quality"},{"key":"113_CR24","volume-title":"Version 9.2","author":"SAS","year":"2009","unstructured":"SAS: Version 9.2. 2009, Cary, NC: SAS Institute Inc"},{"key":"113_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/acprof:oso\/9780195326543.001.0001","volume-title":"Systematic Reviews and Meta-analysis","author":"JH Littell","year":"2008","unstructured":"Littell JH, Corcoran J, Pillai V: Systematic Reviews and Meta-analysis. 2008, New York: Oxford University Press"},{"key":"113_CR26","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1111\/j.1541-0420.2010.01498.x","volume":"67","author":"J Carpenter","year":"2011","unstructured":"Carpenter J, Rucker G, Schwarzer G: Assessing the sensitivity of meta-analysis to selection bias: a multiple imputation approach. Biometrics. 2011, 67: 1066-1072. 10.1111\/j.1541-0420.2010.01498.x.","journal-title":"Biometrics"},{"key":"113_CR27","unstructured":"The bugs project, Winbugs.http:\/\/www.mrc-bsu.cam.ac.uk\/bugs\/winbugs\/contents.shtml,"},{"key":"113_CR28","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1002\/sim.1875","volume":"23","author":"G Lu","year":"2004","unstructured":"Lu G, Ades AE: Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med. 2004, 23: 3105-3124. 10.1002\/sim.1875.","journal-title":"Stat Med"},{"key":"113_CR29","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1214\/ss\/1177011136","volume":"7","author":"A Gelman","year":"1992","unstructured":"Gelman A, Rubin DB: Inference from iterative simulation using multiple sequences. Stat Sci. 1992, 7: 457-472. 10.1214\/ss\/1177011136.","journal-title":"Stat Sci"},{"key":"113_CR30","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/sim.3767","volume":"29","author":"S Dias","year":"2010","unstructured":"Dias S, Welton NJ, Caldwell DM, Ades AE: Checking consistency in mixed treatment comparison meta-analysis. Stat Med. 2010, 29: 932-944. 10.1002\/sim.3767.","journal-title":"Stat Med"},{"key":"113_CR31","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.jclinepi.2008.10.001","volume":"62","author":"G Salanti","year":"2009","unstructured":"Salanti G, Marinho V, Higgins JP: A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered. J Clin Epidemiol. 2009, 62: 857-864. 10.1016\/j.jclinepi.2008.10.001.","journal-title":"J Clin Epidemiol"},{"key":"113_CR32","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1464-5491.2007.02078.x","volume":"24","author":"MN Cook","year":"2007","unstructured":"Cook MN, Girman CJ, Stein PP, Alexander CM: Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care. Diabet Med. 2007, 24: 350-358.","journal-title":"Diabet Med"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2046-4053-2-47.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/2046-4053-2-47\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2046-4053-2-47","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/2046-4053-2-47.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:35:45Z","timestamp":1630542945000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/2046-4053-2-47"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,28]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["113"],"URL":"https:\/\/doi.org\/10.1186\/2046-4053-2-47","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,28]]},"assertion":[{"value":"25 February 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"47"}}